Large-scale survey to describe acne management in Brazilian clinical practice

Figures & data

Figure 1 Most frequent acne grade received by dermatologists in clinic (n=573).

Figure 2 Percentage of dermatologists choosing each treatment choice for grade I acne patients (n=596).

Notes: Yellow bars, topical medication; red bars, systemic medication.
Abbreviation: BPO, benzoyl peroxide.

Table 1 Percentage of dermatologists choosing topical and/or oral medication options in relation to the acne grade of acne patients

	Grade I	Grade II	Grade III	Grade IV
Topical treatment with medication (yes)	94%	98%	83%	56%
Systemic treatment with medication (yes)	28%	64%	96%	98%

Figure 3 Percentage of dermatologists choosing each treatment choice for grade II acne patients (n=596).

Notes: Yellow bars, topical medication; red bars, systemic medication.
Abbreviation: BPO, benzoyl peroxide.

Figure 4 Percentage of dermatologists choosing each treatment choice for grade III acne patients (n=596).

Notes: Yellow bars, topical medication; red bars, systemic medication.
Abbreviation: BPO, benzoyl peroxide.

Figure 5 Percentage of dermatologist choosing each treatment choice for grade IV acne patients (n=596).

Notes: Yellow bars, topical medication; red bars, systemic medication.
Abbreviation: BPO, benzoyl peroxide.

Table 2 Percentage of dermatologists choosing dermocosmetics in relation to the acne grade of acne patients

	Grade I	Grade II	Grade III	Grade IV
Dermocosmetic(s) (yes)	75.0%	67.3%	55.7%	44.1%
Morning	34.0%	25.0%	18.0%	17.0%
Evening	31.0%	20.0%	16.0%	15.0%
Average number of applications per day	1.65	1.68	1.74	1.79
In adjunctive therapy only (yes)	56.8%	65.8%	69.3%	70.9%
With topical medication only	73.7%	70.6%	58.2%	61.9%
With systemic medication only	00.7%	04.0%	10.3%	14.2%
With both	25.6%	25.4%	31.5%	23.9%
In maintenance therapy only (yes)	20.0%	16.8%	14.7%	11.7%
With topical medication	82.3%	76.0%	72.4%	73.1%
With systemic medication	00.0%	01.0%	01.7%	01.9%
With both	17.7%	22.9%	25.9%	25.0%
In monotherapy	07.0%	01.0%	03.0%	02.0%

Table 3 Percentage of dermatologists choosing dermocosmetic prescription for grades I to IV acne, by region

	SP (253)	RJ/ES (104)	MG (91)	South (84)	Rest (64)
Grade I	85%	77%	59%	86%	67%
Grade II	78%	70%	60%	73%	62%
Grade III	64%	50%	52%	63%	45%
Grade IV	47%	52%	47%	55%	23%

Abbreviations: SP, São Paulo; RJ, Rio de Janeiro; ES, Espírito Santo; MG, Minas Gerais.

Figure 6 Acne therapeutic algorithm developed by GILEA during the CILAD 2014. Reproduced from Ibero Latina American Collage of Dermatology (CILAD). Available from: http://www.cilad.org/archivos/1/GILEA/alg_eng1.pdf.¹²

Abbreviations: NSAIDS, non-steroidal anti-inflammatories; BCP, birth control pills.

Table 4 Acne severity classification according to the SBD, Global Alliance to Improve Outcomes in Acne, or GILEA

SBD	Global Alliance to Improve Outcomes in Acne^Citation8,Citation9	GILEA^Citation11,Citation12
Grade I	Mild – comedonal	Comedonal
Grade II	Mild – mixed and papular/pustular	Papular/pustular mild
	Moderate – mixed and papular/pustular	Papular/pustular moderate
Grade III	Moderate – mixed and papular/pustular	Papular/pustular severe
	Moderate – nodular (with small nodules <0.5 cm)	Nodular mild
Grade IV	Severe – nodular/conglobate	Nodular moderate Nodular severe

Abbreviations: SBD, Brazilian Society of Dermatology; GILEA, Ibero Latin American Group of Study of Acne.

ACNE – THERAPEUTIC ALGORITHM, from the Ibero Latin American Group of Study of Acne (GILEA): scientific group of the Ibero Latina American Collage of Dermatology (CILAD) Available from: http://www.cilad.org/archivos/1/GILEA/alg_eng1.pdfAccessed November 28, 2014

 Google Scholar

GollnickHCunliffeWBersonDGlobal Alliance to Improve Outcomes in AcneManagement of acne: a report from a Global Alliance to Improve Outcomes in AcneJ Am Acad Dermatol200349S1S3712833004

 PubMed Web of Science ®Google Scholar

DrénoBThiboutotDGollnickHGlobal Alliance to Improve Outcomes in AcneLarge-scale worldwide observational study of adherence with acne therapyInt J Dermatol20104944845620465705

 PubMed Web of Science ®Google Scholar

KaminskyAFlorez-WhiteMAriasMIBagatinEen nombre del Grupo Ibero Latinoamericano de Estudio del Acné (GILEA-CILAD)Clasificación del acné: Consenso Ibero-Latinoamericano, 2014Med Cutan Iber Lat Am20154311823

 Google Scholar